News
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC
EMA committee recommends approval of BeOne Medicines’ Tevimbra to treat neoadjuvant/adjuvant NSCLC: San Carlos, California Wednesday, July 30, 2025, 12:00 Hrs [IST] BeOne Medici ...
Agilent supports India’s global biopharma ambitions with state-of-the-art experience center in Hyderabad: Our Bureau, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback